x

Posted 15 March, 2023

Enovis CORP appointed new CEO

CEO Change detected for ticker NYSE:ENOV in a 8-K filed on 15 March, 2023.


  On March 14, 2023, Mitchell P. Rales notified the Board of Directors (the "Board") of Enovis Corporation (the "Company") that he will not stand for re-election as a director and will retire from the Board upon the expiration of his term at the Company's 2023 Annual Meeting of Stockholders (the "Annual Meeting") on May 16, 2023. In connection with and effective as of Mr. Rales' retirement, the size of the Board will be reduced by one to ten directors and, subject to their re-election to the Board at the Annual Meeting, Matthew L. Trerotola, the Company's Chief Executive Officer and a current director, will become Chair of the Board and independent director Sharon Wienbar will become Lead Independent Director.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Enovis CORP
Health Care/Life Sciences • Medical Equipment/Supplies
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Market Cap
$3.39B
View Company Details
Enovis CORP by TradingView
Relevant filing section
Item 5.02. 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


(b) 

On March 14, 2023, Mitchell P. Rales notified the Board of Directors (the "Board") of Enovis Corporation (the "Company") that he will not stand for re-election as a director and will retire from the Board upon the expiration of his term at the Company's 2023 Annual Meeting of Stockholders (the "Annual Meeting") on May 16, 2023. In connection with and effective as of Mr. Rales' retirement, the size of the Board will be reduced by one to ten directors and, subject to their re-election to the Board at the Annual Meeting, Matthew L. Trerotola, the Company's Chief Executive Officer and a current director, will become Chair of the Board and independent director Sharon Wienbar will become Lead Independent Director.